Literature DB >> 15518930

Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning.

K Richard Ridderinkhof1, Wery P M van den Wildenberg, Sidney J Segalowitz, Cameron S Carter.   

Abstract

Convergent evidence highlights the differential contributions of various regions of the prefrontal cortex in the service of cognitive control, but little is understood about how the brain determines and communicates the need to recruit cognitive control, and how such signals instigate the implementation of appropriate performance adjustments. Here we review recent progress from cognitive neuroscience in examining some of the main constituent processes of cognitive control as involved in dynamic decision making: goal-directed action selection, response activation and inhibition, performance monitoring, and reward-based learning. Medial frontal cortex is found to be involved in performance monitoring: evaluating outcome vis-a-vis expectancy, and detecting performance errors or conflicting response tendencies. Lateral and orbitofrontal divisions of prefrontal cortex are involved in subsequently implementing appropriate adjustments.

Entities:  

Mesh:

Year:  2004        PMID: 15518930     DOI: 10.1016/j.bandc.2004.09.016

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  444 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

2.  Task difficulty modulates age-related differences in the behavioral and neural bases of language production.

Authors:  Haoyun Zhang; Anna Eppes; Michele T Diaz
Journal:  Neuropsychologia       Date:  2018-12-01       Impact factor: 3.139

3.  Right hemispheric participation in semantic decision improves performance.

Authors:  Kiely M Donnelly; Jane B Allendorfer; Jerzy P Szaflarski
Journal:  Brain Res       Date:  2011-09-02       Impact factor: 3.252

4.  Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.

Authors:  Tessa Christodoulou; Lambros Messinis; Panagiotis Papathanasopoulos; Sophia Frangou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-22       Impact factor: 5.270

5.  Brain oscillatory activity associated with task switching and feedback processing.

Authors:  Toni Cunillera; Lluís Fuentemilla; Jose Periañez; Josep Marco-Pallarès; Ulrike M Krämer; Estela Càmara; Thomas F Münte; Antoni Rodríguez-Fornells
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

6.  Neurocognitive deficits in male alcoholics: an ERP/sLORETA analysis of the N2 component in an equal probability Go/NoGo task.

Authors:  A K Pandey; C Kamarajan; Y Tang; D B Chorlian; B N Roopesh; N Manz; A Stimus; M Rangaswamy; B Porjesz
Journal:  Biol Psychol       Date:  2011-10-21       Impact factor: 3.251

7.  Attention bias modification reduces neural correlates of response monitoring.

Authors:  Brady D Nelson; Felicia Jackson; Nader Amir; Greg Hajcak
Journal:  Biol Psychol       Date:  2017-09-01       Impact factor: 3.251

Review 8.  Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.

Authors:  Rebecca J Houston; Nicolas J Schlienz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23

Review 9.  Cerebral network disorders after stroke: evidence from imaging-based connectivity analyses of active and resting brain states in humans.

Authors:  Anne K Rehme; Christian Grefkes
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

10.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.